Alexander Nowak
Stock Analyst at Craig-Hallum
(2.63)
# 2,089
Out of 4,896 analysts
45
Total ratings
44.44%
Success rate
5.77%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $6.81 | +223.05% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $160.43 | -2.14% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.97 | +143.90% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $30.34 | +87.87% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $13.63 | +98.09% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.13 | -25.48% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $3.63 | +120.39% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.90 | +520.69% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $15.59 | +220.72% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.72 | +1,012.66% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $51.91 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.71 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.25 | +388.89% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $54.14 | +103.18% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.50 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $6.82 | +4,298.83% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.80 | +382.76% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $6.81
Upside: +223.05%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $160.43
Upside: -2.14%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.97
Upside: +143.90%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $30.34
Upside: +87.87%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $13.63
Upside: +98.09%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.13
Upside: -25.48%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $3.63
Upside: +120.39%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.90
Upside: +520.69%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $15.59
Upside: +220.72%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.72
Upside: +1,012.66%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $51.91
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.71
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.25
Upside: +388.89%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $54.14
Upside: +103.18%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.50
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $6.82
Upside: +4,298.83%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $5.80
Upside: +382.76%